Ergomed Share Discussion Threads

[mfhmfh] 23/11/2019 10:55

positive results re: immunotherapy in head & neck cancers.

[firtashia] 23/11/2019 09:08

Nimbo1, nobilis- please accept my apologies for attracting my own personal troll to your comments :-))

[nobilis] 22/11/2019 15:21

TASTAYYYYYYY 400p

[nimbo1] 22/11/2019 06:40

Thanks firtashia - v useful to know.

[firtashia] 21/11/2019 21:00

Nimbo1- Just noticed forward Eps estimates have been revised upwards-might be the reason for the recent share price movement.

[onjohn] 21/11/2019 18:48

why do that. This is going to £10

[john09] 21/11/2019 14:24

I can sell 7,500 at £3.86 easy

[john09] 21/11/2019 14:10

This is a pure and simple re-rate

[nimbo1] 21/11/2019 13:53

i bought this at 300 after reading SCSW - shares tend not to rise like this unless something is happening...im eager to know! Granted of course they can run for a while before the news comes out but there must be something...

[john09] 21/11/2019 13:42

😋 yep new leg up commenceth

[mfhmfh] 21/11/2019 13:37

386 being paid now

[mfhmfh] 20/11/2019 16:36

approx. £53,000 buy at 377.7p

[onjohn] 20/11/2019 09:08

Looking to shoot over 400

[sunningdale1] 15/11/2019 16:02

Ergomed a stock that just keeps on giving - my best buy for 2019. Let's hope for a strong finish to the year.

For those interested in other growing Pharma stocks, big news this week from Open Orphan! Venn Life Sciences, which is part of the ORPH group has been selected as the preferred partner for pharma heavy weights Ipsen Group’s ( Data Management and Biostatistics. The preferred vendor structure will last for a 3-year period. Ipsen had sales in excess of €2.2 billion last year.

This partnership has already delivered substantial revenues for the Open Orphan group and positions the business as an integrated drug development partner for Biopharma companies in Europe such as Ipsen.

This partnership is the first of many steps to make Venn profitable and deliver a re-rating of the business to be in line with the wider sector.

CEO Cathal Friel summaries the significance of the agreement in 2 minute video below.

[nw99] 14/11/2019 17:48

Did expect a seller other with those buys stock would have been up large

[ih_198062] 14/11/2019 17:33

RNS Filed

1. Oryx International Growth Fund Limited

2. North Atlantic Smaller Companies Investment Trust PLC

They sold 1M shares

[john09] 13/11/2019 19:15

Forward PE OF 21 TOOOOO CHEAP FOR THIS. Expect more upgrades too 👌😏

[john09] 13/11/2019 16:37

Closed at 3.78 👌

[john09] 13/11/2019 15:51

This moved from £1.60 to £3.10 vertically . I wonder where this new move up will stop...

[abarclay] 13/11/2019 15:24

Looking for 450 here quite quite quick, 600-700p mid term

Today’s buyers of 900k at 375p are confident

[sammyshares] 13/11/2019 15:14

likely to pull back.

[john09] 13/11/2019 15:14

Just had a look at Sammys posts. He’s posted that on pretty much everything.

Filtered